vegfr2-169
Vaccineexperimental
Clinical trial activity
3 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Nov 1, 2006 (NCT00622622)
Timeline
2000s
- Jan 1, 2006
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Vascular endothelial growth factor receptor 2Immunity, active
KDR immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- vegfr2-169
- vegfr2-169
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00655785 | Phase 1/Phase 2 (Phase 2) | Sep 1, 2007 | Fukushima Medical University, University of Tokyo |
| NCT00639925 | Phase 1 | Mar 1, 2007 | Fukushima Medical University, University of Tokyo |
| NCT00622622 | Phase 1 | Nov 1, 2006 | University of Tokyo, Wakayama Medical University |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| University of Tokyo | Academic/Hospital | 3 | 0 | 2 | 2006 |
| Fukushima Medical University | Academic/Hospital | 2 | 2 | 2 | 2007 |
| Wakayama Medical University | Academic/Hospital | 1 | 1 | 1 | 2006 |
3 organizations
Page 1 / 1